Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin

Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin

Bibliographic Details
Main Author:	Felipe Aizpuru
Format:	Article
Language:	English
Published:	Wiley 2017-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials adverse drug event clinical trial regulation of research
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.006018

Similar Items

Adverse events and nocebo phenomena: treatment or disease specific?
by: Panagiotis Zis, et al.
Published: (2019-02-01)

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01)

Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting
by: Gwenllian Moody, et al.
Published: (2019-12-01)

The Adverse Event Paradox
by: Thomas Milovac
Published: (2022-05-01)

The SMART Safety: An empirical dataset for evidence synthesis of adverse events
by: Shiqi Fan, et al.
Published: (2023-12-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2018-10-01)

Advantages of visualisations to evaluate and communicate adverse event information in randomised controlled trials
by: Victoria Cornelius, et al.
Published: (2020-12-01)

On the dark side of therapies with immunoglobulin concentrates. The adverse events
by: Peter J. Spaeth, et al.
Published: (2015-02-01)

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
by: Elizabeth C. James, et al.
Published: (2020-09-01)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
by: Ruoning Yang, et al.
Published: (2022-05-01)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
by: Aditi Anand Apte
Published: (2016-01-01)

Adverse events: an expensive and avoidable hospital problem
by: Diego San Jose-Saras, et al.
Published: (2022-12-01)

Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids
by: Ciro Manzo, et al.
Published: (2018-08-01)

Appraisal of Intraoperative Adverse Events to Improve Postoperative Care
by: Larsa Gawria, et al.
Published: (2023-03-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
by: Márcio A. Diniz, et al.
Published: (2021-11-01)

Inductive Characterization of ENDS-Associated Adverse Events Among California Young Adults
by: Joshua S. Yang, PhD, MPH, et al.
Published: (2022-12-01)

Rheumatological Adverse Events Following Immunotherapy for Cancer
by: Ioana Cretu, et al.
Published: (2022-01-01)

Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023-01-01)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events
by: Stephanie L. Gu, et al.
Published: (2023-11-01)

Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials
by: Brigitte Cheuvart, et al.
Published: (2023-12-01)

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis
by: Hou H, et al.
Published: (2019-05-01)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024-04-01)

Signal mining and analysis for adverse events of avatrombopag based on FAERS
by: XIONG Rui, et al.
Published: (2024-02-01)

Adverse drug events caused by medication errors in medical inpatients
by: B Hardmeier, et al.
Published: (2004-11-01)

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
by: Hong Yu, et al.
Published: (2019-05-01)

Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis
by: Wen Lei, et al.
Published: (2021-08-01)

ANABOLIC ANDROGENIC STEROIDS AND ADVERSE EVENTS OF THEIR APPLICATION
by: Nina Đukanović, et al.
Published: (2011-08-01)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
by: Yunyan Pan, et al.
Published: (2024-04-01)

Reducing preventable adverse events in obstetrics by improving interprofessional communication skills – Results of an intervention study
by: Beate Hüner, et al.
Published: (2023-01-01)

Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis
by: Chong Chen, et al.
Published: (2022-05-01)

Improving analysis practice of continuous adverse event outcomes in randomised controlled trials - a distributional approach
by: Anca Chis Ster, et al.
Published: (2021-06-01)

Cosmetics utilization and associated adverse events: A community based cross-sectional study
by: Sweta Kumari, et al.
Published: (2023-09-01)

Editorial: Immune-related adverse events for patients with lung cancer-volume II
by: Yusha Wang, et al.
Published: (2023-11-01)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2023-05-01)

Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysis
by: Jinming Li, et al.
Published: (2023-10-01)

Smallpox Vaccination and Adverse Cardiac Events
by: Lorna E. Thorpe, et al.
Published: (2004-05-01)

ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE ELDERLY
by: Lúcia Helena Linheira-Bisetto, et al.
Published: (2016-12-01)